Article Information
History
- February 7, 2020.
Article Versions
- Version 1 (April 26, 2019 - 15:28).
- Version 2 (July 26, 2019 - 17:19).
- You are currently viewing Version 3 of this article (February 7, 2020 - 03:00).
- View Version 4, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Timothy V. Pyrkova,*,
- Konstantin Avchaciova,
- Andrei E. Tarkhova,b,
- Leonid I. Menshikova,c,
- Andrei V. Gudkovd,e and
- Peter O. Fedicheva,f
- aGero LLC, 105064, Nizhny Susalny per. 5/4, Moscow, Russia
- bSkolkovo Institute of Science and Technology, Bolshoy Boulevard 30, bld. 1, Moscow 121205, Russia
- cNational Research Center “Kurchatov Institute”, 1, Akademika Kurchatova pl., Moscow 123182, Russia
- dRoswell Park Comprehensive Cancer Center, Elm and Carlton streets, Buffalo, NY 14263, USA
- eGenome Protection, Inc. 640 Ellicott St #444, Buffalo, NY 14203, USA
- fMoscow Institute of Physics and Technology, 141700, Institutskii per. 9, Dolgoprudny, Moscow Region, Russia
- ↵*To whom correspondence should be addressed. E-mail: tim.pyrkov{at}gero.com, peter.fedichev{at}gero.com
Posted February 07, 2020.
Longitudinal analysis of blood markers reveals progressive loss of resilience and predicts ultimate limit of human lifespan
